Partner at @TrustPointe and Owner of @TareAPI. Chemist, Engineer, Corporate Veep. Interests include Finance, Science, Entrepreneurship. Views are my own.
@BigPeptideGuy@PepRoundUp@5StarLabs It’s more than that
It’s also brand reputation. Even if people knew, people that can afford it will perceive HIMS to be better quality product than some rando selling it to them for $6/vial (whether or not it’s true)
Price communicates more than just price
This is accurate
USP <71> is looking for aseptic process failures under the assumption there was an aseptic process in the first place.
For this reason, 20 vials were considered sufficient statistical power for the test.
If we were going for high statistical power:
59 samples, 0 failures = 95% confidence / 95% conformance
300 samples, 0 failures = 95 % confidence, 99% conformance
The only reason HIMS can charge $189/mo is the black market premium. The pharmaceutical industry with its massive existing infrastructure has not entered the peptide market due to regulatory risk.
You think the moment that regulatory risk is fully eliminated the entire pharma supply chain won’t step in and drown out this HIMS nonsense?
Epitalon will come from China and India too, just like every lot of ibuprofen API does today.
You’re out of your element bud.
At best this is a bet that they can thread the needle before the entire path to legalization is blocked again. At worst, this is massive investment in a space they will never be able to compete in once legalized.
@PioneerPeptides@ergonoatia Agreed.
Without seeing actual chromatography it’s hard to know if that was the sum of a lot of small peaks or one big peak, which would likely be above the signal-to-noise ratio.
@PepRoundUp@5StarLabs Yeah. You’re smarter than 99% of the business world that moves all labor to low cost labor countries China, India, Cambodia, etc.
I love the confidence tho!
💀💀💀
Final point: when you’re talking 0.3%, I’m guessing a lot of these impurity peaks being integrated are below a reasonable Signal-to-Noise threshold and shouldn’t be integrated anyway - especially since we can’t validate for each impurity.
I’ve talked about implementing a Signal-to-Noise threshold at TrustPointe, which would result in a lot more 100% purity results.
But then in addition to trying to explain method validation (which few get) I’d be explaining why I have higher purity values than everyone else, even tho everyone else’s results are really below a reasonable analytical threshold.
I’m sure peptide vendors would love it - but even with them on board explaining it to the RUO base is basically an impossible task.
No thanks 😂 I’m still trying to get people to adopt method validation as a minimum standard for a lab.
@ergonoatia Maybe it’s more accurate to say “has the best method for that peptide SAMPLE”
TrustPointe may find an impurity another lab does not, and vice versa on a single sample, but then the opposite may be true on the next sample (different process impurities, etc)
@ColtFirearms Versus what?
Someone that uses labs with non-validated methods and thinks PCR is a sterility test?
I’ll take my peptides without acinetobacter, thank you
Only one I trust
He was on the “PCR sterility is bullshit” bandwagon long before anyone here noticed
Cares about what the tests mean and that they’re validated